Clinical Trials in Pittsburgh

Showing 20921-20940 of 21,047 trials

A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment

NCT00002216

The purpose of this study is to compare 2 combination drug therapies in HIV-infected patients who have never received anti-HIV treatment.

HIV Infections

Glaxo Wellcome

Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

A Study of Timunox (Thymopentin) in HIV-Infected Patients Receiving Other Anti-HIV Drugs

NCT00002332

To evaluate the mechanism whereby thymopentin appears to retard the progressive immune suppression attributable to HIV infection.

HIV Infections

Immunobiology Research Institute60 participants

San Francisco, California, United States • Tarzana, California, United States • Pittsburgh, Pennsylvania, United States

COMPLETEDNA< 1 mile

The Effects of AZT and Ibuprofen on HIV-Infected Patients With Hemophilia

NCT00002276

To determine if platelet dysfunction and/or pharmacologic drug interaction occurs in patients taking both AZT and ibuprofen, which might account for enhanced bleeding tendency.

HIV InfectionsHemophilia A

University of Pittsburgh

Pittsburgh, Pennsylvania, United States

COMPLETEDPhase 3< 1 mile

Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy

NCT00002109

To confirm results from a previous study in which the combination of thymopentin plus zidovudine ( AZT ), an antiretroviral agent, slowed disease progression in HIV-infected asymptomatic patients. To evaluate the efficacy and safety of thymopentin in HIV-infected asymptomatic patients receiving either monotherapy with AZT, didanosine ( ddI ), or stavudine ( d4T ), or combination antiretroviral therapy with AZT / ddI or AZT / zalcitabine ( ddC ).

HIV Infections

Immunobiology Research Institute

Phoenix, Arizona, United States • Irvine, California, United States • Los Angeles, California, United States +47 more locations

A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment

A Study of Timunox (Thymopentin) in HIV-Infected Patients Receiving Other Anti-HIV Drugs

The Effects of AZT and Ibuprofen on HIV-Infected Patients With Hemophilia

Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy

Find Trials by Condition in Pittsburgh

Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients

The Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study

Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients

The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs

A Study to Compare Two Anti-HIV Drug Combinations

Comparing Side Effects of Two Forms of Videx in HIV-Infected Adults

A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis

A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis

A Study of Different Doses of Atevirdine Mesylate Plus Zidovudine in HIV-Positive Patients

The Safety and Effectiveness of PMPA Prodrug in HIV-Infected Patients

Lidorestat (IDD 676) for the Treatment of Diabetic Neuropathy

A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDS

An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children

A Study of Letrazuril in the Treatment of AIDS-Related Diarrhea

Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOP

A Randomized Phase II Efficacy, Activity and Safety Study of GLQ223 Alone and in Combination With Zidovudine in Symptomatic HIV-Infected Patients Without Prior Treatment With GLQ223 or Trichosanthin